Highly Accomplished Executives Join BioVie’s Board of Directors

NEXT STORY
Oligonucleotide Synthesis Market Worth $3.9 Billion by 2025, Growing at a CAGR of 10.4% from 2019- Global Opportunity Analysis and Industry Forecasts by Meticulous Research®
PREV STORY
Biomerica files for FDA Emergency Use Authorization (EUA) of its Unique Laboratory Antibody Test for COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Kura Oncology Granted U.S. Patent for Clinical-Stage ERK Inhibitor, KO-947

LA JOLLA, Calif., April 19, 2017 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (NASDAQ:KURA), a ...

author_avatar
NASDAQ Market News

BeyondSpring to Present Clinical Trial Data at Three Upcoming Scientific Conferences

NEW YORK, Oct. 03, 2018 (GLOBE NEWSWIRE) -- BeyondSpring Inc. (NASDAQ:BYSI), a global, clinical-stage ...

author_avatar
NASDAQ Market News

Cellectar’s Radiotherapeutic PDCs Demonstrate an Increased Survival Benefit Using Multiple Doses in Preclinical Studies

MADISON, Wis., April 27, 2017 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (Nasdaq:CLRB), (the “company”), ...

author_avatar
NASDAQ Market News